Nova Patents
IS6015A

Cyclic substituted fused pyrrolocarbazoles and isoindolones

Abstract

The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones having formula (I). The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones. The compounds are useful as agents for the regulation of protein kinase.

Term

Term ended

Projected expiry passed 20 July 2021, 5.2 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

36 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
11983499United States of AmericaP
50084900United States of AmericaA
0003476United States of AmericaW
PCTUS0003476–––
US19990119834P–––
US20000500849–––
WO2000US03476–––

Members36

Family members, oldest first
DocumentOfficeKind
CA2359772A1CanadaA1
WO0047583A1World Intellectual Property Organization (WIPO)A1
AU3360400AAustraliaA
WO0047583A8World Intellectual Property Organization (WIPO)A8
IS6015AThis recordIcelandA
NO20013887D0NorwayD0
WO0047583A9World Intellectual Property Organization (WIPO)A9
NO20013887LNorwayL
KR20010102085ARepublic of KoreaA
EP1165562A1European Patent Office (EPO)A1
HU0105363D0HungaryD0
EA200100887A1Eurasian Patent Organization (EAPO)A1
SK11292001A3SlovakiaA3
BR0008056ABrazilA
CN1350537AChinaA
BG105890ABulgariaA
HUP0105363A2HungaryA2
TR200102338T2TürkiyeT2
CZ20012878A3CzechiaA3
HRP20010583A2CroatiaA2
AR024853A1ArgentinaA1
PL352530A1PolandA1
ZA200106364BSouth AfricaB
JP2003529537AJapanA
AU773335B2AustraliaB2
NZ513097ANew ZealandA
US2004186157A1United States of AmericaA1
HUP0105363A3HungaryA3
EA005273B1Eurasian Patent Organization (EAPO)B1
US6841567B1United States of AmericaB1
US2006128780A1United States of AmericaA1
US7074793B2United States of AmericaB2
NO322210B1NorwayB1
KR100697732B1Republic of KoreaB1
US7288650B2United States of AmericaB2
CA2359772CCanadaC